CAG
TXG icon

Crestwood Advisors Group’s 10x Genomics TXG Stock Holding History

Crestwood Advisors Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$925K Buy
24,126
+2,099
+10% +$55K 0.01% 334
2026
Q1 		$468K Buy
22,027
+7,335
+50% +$147K 0.01% 442
2025
Q4 		$240K Buy
+14,692
New +$222K ﹤0.01% 603

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Crestwood Advisors Group's TXG Position: Q2 2026 in Review

Crestwood Advisors Group increased its 10x Genomics (TXG) stake by 9.5% in Q2 2026, buying an estimated $55K and bringing the position to 24,126 shares worth $925K. The position accounts for 0.01% of the portfolio, ranked #334.

Crestwood Advisors Group first reported a position in TXG in Q4 2025 and has held it in 3 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Crestwood Advisors Group held 24,126 shares of 10x Genomics worth $925K as of Q2 2026.
  • Crestwood Advisors Group bought 2,099 10x Genomics shares in Q2 2026, an estimated $55K.
  • 10x Genomics made up 0.01% of Crestwood Advisors Group's portfolio in Q2 2026, its #334 holding.
  • Crestwood Advisors Group first reported a position in 10x Genomics in Q4 2025 and has held it in 3 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.